Logo

Roy Smythe

Nov 15, 2018

Roy Smythe has been appointed as CEO of SomaLogic. He will replace Alister Reynolds, who became CEO in early 2017 and who will remain on the company's board. Smythe joins the Boulder, Colorado-based firm from Royal Philips, where he was chief medical officer for strategy and partnerships. Prior to that, he was CMO at Valence Health, and before that, CMO of healthcare technology accelerator AVIA. Previously, he was chair of the Department of Surgery at Baylor Scott & White Health and the Texas A&M Health Science Center College of Medicine, where he was also medical director of innovation.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.